BG-85738 / BeOne Medicines - LARVOL DELTA

A First-in-Human Study Investigating BG-85738 Alone or in Combination With Other Antitumor Agents in Patients With Advanced or Metastatic Solid Tumors With Rat Sarcoma Virus (RAS) Mutations (clinicaltrials.gov) - P1 | N=100 | Recruiting | Sponsor: BeOne Medicines | Not yet recruiting ➔ Recruiting

Enrollment open • First-in-human • Oncology • Sarcoma • Solid Tumor • HRAS • KRAS • NRAS • RAS

A First-in-Human Study Investigating BG-85738 Alone or in Combination With Other Antitumor Agents in Patients With Advanced or Metastatic Solid Tumors With Rat Sarcoma Virus (RAS) Mutations (clinicaltrials.gov) - P1 | N=100 | Not yet recruiting | Sponsor: BeOne Medicines

First-in-human • New P1 trial • Oncology • Sarcoma • Solid Tumor • HRAS • KRAS • NRAS • RAS